A carregar...
Adding Vitamin E-TPGS to the Formulation of Genexol-PM: Specially Mixed Micelles Improve Drug-Loading Ability and Cytotoxicity against Multidrug-Resistant Tumors Significantly
Genexol-PM, produced by Samyang Company (Korea) is an excellent preparation of paclitaxel (PTX) for clinical cancer treatment. However, it cannot resolve the issue of multidrug resistance (MDR)—a significant problem in the administration of PTX to cancer patients. To increase the efficacy of Genexol...
Na minha lista:
Publicado no: | PLoS One |
---|---|
Main Authors: | , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Public Library of Science
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4382049/ https://ncbi.nlm.nih.gov/pubmed/25831130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0120129 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|